Form 4 for IMA ImageneBio, Inc.

Accepted 2026-08-17 17:00:13 ET · period of report 2026-08-14 · accession 0001803794-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-08-17 17:00	2026-08-14	IMA	Yarema Kristin	CEO, Dir	A - Grant	$0.00	+254.8K	493.7K	+107%	$0
DM	2026-08-17 17:00	2026-08-14	IMA	Yarema Kristin	CEO, Dir	A - Grant	$0.00	+387.2K	250.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-08-14	A	A	254,800	$0.00	493,705	D	—	—	(F1) Represents the number of shares of the Issuer's Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on April 14, 2027, and the remaing RSUs will vest in a series of 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
2	Derivative	Employee Stock Option (right to buy)	2026-08-14	A	A	137,200	$0.00	137,200	D	$5.84 · — to 2036-08-13	137,200 Common Stock	(F2) The options vest over four years, with 25% of the shares vesting on April 14, 2027, and the remaining shares vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
3	Derivative	Employee Stock Option (Right to Buy)	2026-08-14	A	A	250,000	$0.00	250,000	D	$5.84 · — to 2036-08-13	250,000 Common Stock	(F3) The options vest over four years in a series of 48 successive equal monthly installments commencing on May 14, 2026, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.